Answers are grounded in this paper and cite their sources.
Pancreatic cancer (PC) is a severe disease with no effective early detection methods. New evidence links microbiota to PC, hinting at its diagnostic potential. Despite no current clinical microbiota biomarkers for PC, a systematic review was conducted to assess microbiota's role in noninvasive PC detection. A systematic review analyzing 16S rRNA sequencing data on pancreatic cancer-related microbiota was conducted. The search on PubMed, Cochrane Library, Embase, and Web of Science conducted on 20 November, 2024, aimed to find studies linking PC with microbiota in noninvasive samples. The analysis centered on the differences in microbial taxa between PC patients and healthy controls. Fifteen studies were included, with 10 focusing on oral, and nine on fecal microbiota. There was significant variation in six bacterial phyla (Fusobacteria, Bacteroidetes, Firmicutes, Actinobacteria, Verrucomicrobia, and Proteobacteria ) between pancreatic cancer patients and controls. While genus-level findings varied, some genera like Leptotrichia showed diagnostic potential. Three diagnostic models using these taxa showed good sensitivity and specificity for pancreatic cancer. The studies suggest a link between microbiota and pancreatic cancer, though no single bacterium stands out as most relevant. Diagnostic models using multiple taxa show promise for early detection of PC. More extensive, well-designed studies are needed to establish microbiota's role in pancreatic cancer screening.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: